Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07642739

Nature as Medicine for the Healing Brain: Utilization of a Nature-based Exposure Intervention for Decreasing Concussion Recovery Timeline and Symptom Load

The overall goal of this research is to provide pilot data that informs and drives a larger scale research project, incorporating multiple contemporary measurement modalities, to understand the utility and pathological mechanisms by which exposure to nature-based settings may aid in recovery time and symptom relief of individuals suffering from concussion, and decrease their risk of developing Persistent Post-Concussion Syndrome (PPCS).

We hypothesize that successful adherence to a nature-based exposure therapy intervention program will decrease recovery time and severity of symptom trajectory of concussion, as measured through multimodal assessments of brain structural and functional integrity.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

14 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Recreation Building

University Park, Pennsylvania, 16802, United States

Location contact

Owen Griffith, PhD

CONTACT

[email protected]

5709858794

Owen Griffith, PhD

PRINCIPAL_INVESTIGATOR

About this study

This study will use a resting state combined electrophysiological-imaging measure of brain region activation, a blood-based measure of neuroinflammatory protein circulation, and a brief but comprehensive neuropsychological functional assessment to identify recovery status of the brain pre- and post-intervention. Measures will be taken at two pre-determined time intervals following concussion for each participant (1-3 days, 28-30 days) and frame the start and end point of a 4-week nature-based exposure therapy intervention program. The self-administered nature-based exposure therapy intervention will consist of 4 weeks of 120 minutes per week (spread over 3-7 days) of nature-based exposure coupled with a guided environmental awareness prompt list per week (Harries et al., 2025; Leão et al., 2025; White et al., 2019).

The primary aim of this study will be to assess the utility of a nature-based exposure therapy intervention in decreasing symptom severity and timeline of concussion. The intervention will include a multi-week program during which patients will participate in a specified duration of emersion in "nature-based environments". This intervention will inform a low-risk, holistic method for concussion management and may decrease risk of PPCS onset. A multimodal measurement battery will assess structural, functional, and behavioral concussion recovery factors as they relate to the nature-based intervention. Trends in recovery measures will be recorded at pre- and post-intervention, as well as throughout the intervention time period to assess both the feasibility/adherence and efficacy of nature-based exposure on recovery from concussion.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Require that any participant is 14-35 years old
  • Required that any participant under 18 years old can be accompanied by a parent or legal guardian for the duration of the study
  • Required that participants be English speakers
  • Required that persons be able to provide consent for themselves
  • Required that the participant must have suffered a clinically diagnoses concussion 5 days or less prior to the first study visit
  • Concussion must have been diagnosed by a licensed clinical medicine professional.
  • No additional professional treatment modalities outside of normal clinical concussion recovery recommendations may have been received prior to study participation. These include participation in a separate concussion rehabilitation study, cognitive behavioral therapies, vestibule-ocular therapies (balance), in-patient physical therapy, consumption of stimulant medication, and chiropractic manipulation.
  • Injury must have been diagnosed as a concussion or mild-traumatic brain injury. Participant must not have been diagnosed with of severe traumatic brain injury, hematoma, fractured skull or facial bones, or comatose.

Exclusion criteria

  • Exclude persons under 14 years old or over 35 years old
  • Exclude persons taking anti-inflammatory drugs (both prescription and OTC), or those who will have taken them within 24 hours prior to Visit 1
  • Exclude smokers and former smokers, as defined by CDC. (Anyone who smokes daily or who has smoked at least 100 cigarettes in their lifetime)
  • Those with presence of an active infection (including a dental infection)
  • Exclude persons who have migraines
  • Exclude persons taking mood stabilizer medications
  • Exclude persons who have consumed alcohol within 48 hours prior to study participation, participants will be asked this by one of the study members through the exclusion criteria screening form when they first contact the study
  • Exclude persons who are pregnant.

Treatment and study plan

Nature-based Guided Awareness Group

Behavioral

Participants in the nature-based guided awareness group will be instructed to perform their intervention prompt in a one of the safe, accessible natural settings provided on the study's Nature-Based Location Guide, 3-7 times per week, for a total duration of 120 minutes per week.

Standard Guided Awareness Group

Behavioral

Participants in the standard guided awareness group will be instructed to perform the prompt in a quiet, controlled indoor environment, 3-7 times per week, for a total duration of 120 minutes per week.

Primary outcomes

  1. Concussion Symptoms Scales

    Time frame: Daily, for the duration of the 28 day study

    All participants will complete daily Post-Concussion Symptom Scale surveys, offering self-report quantifiable measures of concussion recovery.

Secondary outcomes

  1. Stroop Task

    Time frame: On day 1 (visit 1) and day 28 (visit 2) of the 28 day study.

    Neuropsychological test of processing speed and inhibition

  2. Oral Digit Symbol Modalities Task

    Time frame: On day 1 (visit 1) and day 28 (visit 2) of the 28 day study.

    Neuropsychological measure of attention and memory

  3. Beck's Depression Inventory

    Time frame: On day 1 (visit 1) and day 28 (visit 2) of the 28 day study.

    Depression symptom questionnaire

  4. Hamilton Anxiety Scale

    Time frame: On day 1 (visit 1) and day 28 (visit 2) of the 28 day study.

    Anxiety symptom questionnaire

  5. Neuroinflammatory Biomarker Concentration

    Time frame: On day 1 (visit 1) and day 28 (visit 2) of the 28 day study.

    Blood analysis for circulating concentration of neuroinflammatory protein, Interluken-6

  6. EEG-fNRIS

    Time frame: On day 1 (visit 1) and day 28 (visit 2) of the 28 day study.

    Combined EEG-fNIRS brain scan to identify regional brain activation. Specifically a resting state EEG-fNIRS will be utilized to compare the timecourse of frontal theta-, beta-, and alpha-wave peak frequency and absolute power versus BOLD signal (oxygenated hemogloben) in the frontal region. Synchronized EEG and fNIRS scans will aid in confirming type and degree of alterations in subcortical brain activity.

Study contacts

Contact information is provided by the study sponsor or research team.

Owen Griffith, PhD

CONTACT

[email protected]

15709858794

Sponsors and collaborators

Lead sponsor

Penn State University

Other

Collaborators

  • Social Sciences Research Institute at Penn State University

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jun 11, 2026
Registry last updated
Jun 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.